Skip to content

Multidimensional Individualized Nutritional Therapy for Individuals with Severe COPD

Multidimensional INDividualized NUTritional Therapy for Individuals with Severe Chronic Obstructive Pulmonary Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04873856
Acronym
MINDNUT
Enrollment
87
Registered
2021-05-05
Start date
2021-05-21
Completion date
2023-06-14
Last updated
2024-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Keywords

Chronic obstructive pulmonary disease, Health-related quality of life, Nutrition, Mental health, Functional capacity, Anthropometry

Brief summary

Individuals with severe chronic pulmonary disease often life isolated with a high burden of symptoms. Nutritional risk and low quality of life are common, and both associated with increased societal cost and poor prognosis. COPD is a complex and progressive disease with changing clinical states that influences nutritional status and quality of life in different ways. The primary aim is to improve quality of life for individuals with severe COPD. 120 individuals are recruited from the outpatient clinic at Nordsjællands Hospital in Denmark to a randomized controlled trial with two parallel groups (intervention and control). The intervention will last for 3 months comprising four elements including nutritional plan, regular contact, informal caregiver/friendly reminder and a weight dairy. We expect that the intervention will improve quality of life, nutritional status and prognosis.

Interventions

DIETARY_SUPPLEMENTIntervention

The four dimensions of MINDNUT are described below: Nutritional plan: is conducted in collaboration with the participant based on nutritional registration and information about routines and habits to reach a daily protein target of 1.5 g/kg/day. The nutritional plan is adjusted at the regular contact, and nutritional supplementation will be handed out to the participant. Friendly reminder/informal caregiver: is a friendly reminder that encourage the participant to follow the nutritional plan and to ask for support (a note to hang on the refrigerator). The informal caregiver is a person with close contact to the participant. Regular contacts: The participant will be contacted on regular basis (with an interval of 7-14 days) via phone and besides nutritional plan, this conversation will be used to talk about well-being, compliance and potential side-effects. Weight diary: participants is instructed in keeping a weight diary which include registration of a daily weight.

Sponsors

Rigshospitalet, Denmark
CollaboratorOTHER
University of Copenhagen
CollaboratorOTHER
Nordsjaellands Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
35 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ≥ 35 years * Severe COPD defined as GOLD grade 2 group B or D OR GOLD grade 3 and 4 group ABCD * Able to eat orally * Live in own home * Speak Danish or English * Undernourished OR at risk of undernutrition defined as BMI ≤ 21 kg/m2 if \< 70 years and BMI \<22 kg/m2 if ≥70 years OR BMI 21-25 kg/m2 plus nutritional risk (nutritional risk screening score ≥3) if \<70 years and BMI 22-25 kg/m2 plus nutritional risk if ≥70 years * Stable phase CHANGE: Undernourished OR at risk of undernutrition (a maximum BMI of 25 kg/m2) determined by Nutritional Risk Screening 2002 or Mini Nutritional Assessment Short Form according to the protocol published in Trials.

Exclusion criteria

* Active solid cancer defined as cancer diagnosed within the previous six months, recurrent, regionally advanced, or metastatic cancer, cancer for which treatment had been administered within six months or hematological cancer that is not in complete remission * Unable to sign informed consent e.g. due to severe dementia. * Severe chronic renal failure defined as estimated glomerular filtration rate \< 30 mL/min./1.73 m2 (ICD-10 codes N18.4 and N18.5 * Severe alcohol abuse (ICD-10 codes F10.2 and K70.x).

Design outcomes

Primary

MeasureTime frameDescription
Health-related quality of life1 and 3 months after baselineWill be measured using the EQ-5D-5L

Secondary

MeasureTime frameDescription
Weight1 and 3 months after baselineMeasured using an electronic scale (TANITA DC 430 SMA, TANITA, Denmark) to the nearest 0.1 kg
Body mass index1 and 3 months after baselineCalculated as weight (kg)/height (m2)
Hand grip strength1 and 3 months after baselineMeasured using handdynanometer
Lower body strength1 and 3 months after baselineMeasured using 30 second stand chair test
Number of unplanned acute hospitalizations1 and 3 months after baselineObtained from patient files
Number of days in hospital1 and 3 months after baselineObtained from patient files
Number of acute unplanned visits to emergency ward (<6 hours)1 and 3 months after baselineObtained from patient files
Number of contacts to outpatient clinic (visits and phone calls)up to 3 months after baselineObtained from patient files
Disease specific quality of life1 and 3 months after baselineObtained using COPD Assessment test (CAT). CAT contains 8 items with a scoring range of 0-40. The total score indicate the impact level COPD has on the everyday life ranging from low to very high. A total score of 5 is referred to the upper limit of normal in healthy non-smokers, a total score \<10 indicate low impact, 10-20 indicate medium impact, whereas \>20 and \>30 indicate high and very high impact, respectively.
Mortalityup to 3 months after baselinewill be obtained from patient files
Fat-free mass1 and 3 months after baselineMeasured using bioelectrical impedance analysis
Fat mass1 and 3 months after baselineMeasured using bioelectrical impedance analysis

Other

MeasureTime frameDescription
Difference in protein requirement and protein intake1 and 3 months after baselineIntake measured through 24-recall and calculated using MADlog (MADLOG, Denmark) in grams adnd requirements is calculated as 1.5 g/kg/day.
Total energy intake1 and 3 months after baselineMeasured through 24-recall and calculated using MADlog (MADLOG, Denmark) in kalories.
Difference in energy requirement and energy intake1 and 3 months after baselineIntake measured through 24-recall and calculated using MADlog (MADLOG, Denmark) in kalories. Requirements calculated as 30 kcal/kg/day if goal is weight maintenance and 45 kcal kg/day if goal is weight gain
Upper arm circumference1 and 3 months after baselineMeasured using a measuring tape to the nearest 0.1 cm
Hip circumference1 and 3 months after baselineMeasured using a measuring tape to the nearest 0.1 cm
Waist circumference1 and 3 months after baselineMeasured using a measuring tape to the nearest 0.1 cm
Number of exacerbations1 and 3 months after baselineObtained from patient files supplemented with self-reported information
Oxygen therapy1 and 3 months after baselineSelf-reported. The participant is asked if he/she is currently using home oxygen.
Anxiety and depression1 and 3 monthsMeasured using Hospital Anxiety and Depression Scale. The scale contains two subscales to evaluate risk of anxiety and depression. Each subscale contains 7 items with a total score from 0-21. Risk of anxiety and depression are based on a total score ≥8.
Physical activity (subjective)1 and 3 months after baselineMeasured using the physical activity and vial signs questionnaire
Physical activity (objective)7 days from 1- months follow-up and 7 days from 3 months follow-upMeasured using accelerometers (Activity AX3, Newcastle, United Kingdom)
Total protein intake1 and 3 months after baselineMeasured through 24-recall and calculated using MADlog (MADLOG, Denmark) in grams

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026